China Extracorporeal Life Support Registry
1 other identifier
observational
20,000
1 country
1
Brief Summary
Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 7, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
April 9, 2024
April 1, 2024
14 years
November 7, 2019
April 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
All-cause mortality
30 days
Secondary Outcomes (5)
All-cause mortality
365 days
Rate of successful weaning from ECMO
30 days
ECMO-related complications
30 days
Other complications
30 days
Duration stay at ICU and hospital
365 days
Study Arms (3)
Pulmonary Support
ECMO support for acute respiratory failure, ARDS
Cardiac Support
ECMO support for heart failure, cardiogenic shock
Extracorporeal Cardiopulmonary Resuscitation
ECMO support for cardia arrest
Interventions
ECMO for circulatory and/or respiratory support
Eligibility Criteria
Patients receiving ECMO for circulatory and/or respiratory support
You may qualify if:
- Patients receiving ECMO for circulatory and/or respiratory support
You may not qualify if:
- Refusal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
Related Publications (1)
Yuan Z, Liu Y, Wei G, Wang F, Yao B, Hou X, Xing J. Clinical characteristics of extracorporeal cardiopulmonary resuscitation in China: a multicenter retrospective study. BMC Anesthesiol. 2024 Jul 10;24(1):230. doi: 10.1186/s12871-024-02618-2.
PMID: 38987696DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Center for Cardiac Intensive Care
Study Record Dates
First Submitted
November 7, 2019
First Posted
November 8, 2019
Study Start
January 1, 2017
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
April 9, 2024
Record last verified: 2024-04